To Understand the Effect of Grahani Treatment Protocol on Gut Microbiota Flora in Irritable Bowel Syndrome- Mixed

A Pre and Post Test Clinical Study to Evaluate the Effectiveness Of Grahani Treatment Protocol on Gut Microbiota Flora in IBS- Mixed

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/039045

Enrollment

Registered

2021-12-30

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants fulfilling ROME IV CRITERIA 2. Age: 20 - 45 years with no discrimination of sex, caste, religion and economic status 3. Patients identified with the presence of specific strains of Lactobacilli and Bifidobacteria from their fecal samples. 4. Participants from whom the written consent is obtained

Exclusion criteria

Exclusion criteria: 1. Those with the endoscopic findings of peptic ulcer or any organic lesions and other systemic disorders 2. Those on NSAIDâ??s in the last six months, antibiotics or other long-term and continuous medication 3. Patients with alcohol dependency or drug dependency. 4. Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
1. Bristol Stool Form Scale (BSF) 2. VAS (Visual Analog Scale) 3. IBS- SSS (Symptom Rating Scale) 4. IBS- QoL (Quality of Life) Questionnaire 5. Assessment of the Gut Microbiota in the Stool sample (Before and after treatment) Timepoint: 1. Before intervention 0th day 2. After intervention approximately on 50th day	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactDr Devipriya Soman

Amrita School of Ayurveda

priya3656@gmail.com9495638076

Outcome results